Evaluate gives you the understanding and time you need to drive better decisions.
Our clients include the Top 25 global pharma companies, as well as small to mid-sized pharma and biotechs. Evaluate is relied upon by their commercial teams from Business Development & Licensing to Corporate Strategy & Planning, Competitive Intelligence, and Market Analytics.
With solutions suitable for asset screening, market analysis, competitive intelligence and portfolio strategy, Evaluate Pharma reduces the cost, time and risk associated with making strategic decisions.
“ Evaluate's consensus forecasts are the standard at Novartis, and have been for many years, per a mandate from senior management ”
“ Evaluate is easy to use and contains information that helps Zentiva select drugs for future development, particularly the consensus forecasts ”